SlideShare a Scribd company logo
Animal Health Landscape
Andras Bolcskei DVM
Global macroeconomical outlook
AH industry trends
Implication on AH industry
AGENDA
1
2
3
Global macroeconomical outlook
Impacts on Animal Health Industry
Currency & energy prices
War in Ukraine weakens €
Europe’s gas and oil = risk of
recession
Outlook
Dip briefly below parity and to
rally in the next 18 month at
1,02 to 1,08
Consensus
Lower oil price strating from
autumn-end 22 and for the Brent
price to decline $90-95 in 23 and
lower $85-90 in 24
The US dollar is greatly
exagerated
Interest rates are rising faster in
the US = More appealing
Stronger US growth -> increased
invest in the US  increased
demand for dollars
The mid term
PUSH FOR GREENIFICATION
AND RENEWABLES
Impacts on Animal Health Industry
Inflation Growth Unemployment Costs
Recessionary
figures
Lower
growth
(ELAN-)
High demand
labour =War
fot Talent
One-off
bonuses
Rising
Inflation
Producers/Inputs costs is
rising
Growth margins squeezed
Costumers
overall want
value for
money
High single digit
price increase
in 2023
China’s consumer Inflation
Impacts on Animal Health Industry
Implications
CORPORATIZATION
PET PARENT AND
CONSUMER POWER
ATTRACTIVITY
CASH
Cost and availability of
cash is changing which
means that there is again
a cost associated to
taking risk = investors
start being more
selective
In this context,
attractivity of the AH
sector is increased,
especially in Pets, given
the track record of
resilience of the sector
vs. other investment
opportunities. We will
continue to see M&A
activity and R&D
investment in the sector.
It will continue to
increase in the AH, with
megatrends like online
24/7 availability
omnichannel, pet as
family member, steady
increase of pet plans /
pet insurance / data
driven personalization.
This creates value in the
market for agile
companies.
Despite the increased
cost of money, the
predictability and history
of AH and veterinary
business in the last
financial crises and the
early stage of vet clinics
consolidations in many
markets are strong
drivers for continued,
fast-paced
corporatization to
continue.
Animal health industry trends
Consultative
Customers
Transactional
Customers
Know what they want
Treat you as commodity
Digital interaction
Cost focus
Buy on price
Short term
Farms, trades, on-line
shop, independent, etc.
Share problems
Value your value
add
Digital & analogue
interaction
Advice focus
Buy on expertise
and trust
Long term
IL / CA Corporates
& GPOs
DECADE AGO
10% of customers were
one or the other, with the
vast majority somewhere
in the middle, willing to
pay a little extra for some
advice more want deeper
consultative
relationships
more buy
transactionally
TODAY
The middle is going away
as more customers are
moving to the extremes
Customers’ mindset change
Vet Landscape Evolution 2022-2025
Independent
Vet clinics
GPO’s
Corporates
 Companion Animals +++
 Equine consolidating ++
Market consolidation
UK >65%
Netherlands >50%
Germany; Belgium; France >25%
Spain - Poland - Czech
Success factor
aggregating demand
for smaller individual clinics to
stay competitive
Corporate landscape in Europe (data Q2 2022)
A number of large, well capitalized veterinary strategic accounts are expanding
Founded 2011 1999 2001 2015 2011 1987 2000
Ownership
EQT (Silverlake and
Nestlé)
Public Pets At Home BC Partners
Mars
Banfield/VCA
CVC Capital
Partners
Vimian
Surgeries
>2.200
(>900 UK)
>500 >440
>260 in UK &
250 outside UK
450 (+100 in UK) 374
4500 incl
1100 USA
Direct to
Pet owner
PDOL and
MyFamilyVet
Developing online
shop
Yes
VetUK eshop,
hired Amazon
managers
Pilot eshop in
Sweden
Highland
GER
Geographi
Presence
19 countries
Global player
UK, Netherlands,
Republic of
Ireland
UK only
UK, Australia,
New Zealand,
Italy, France
14 countries
Global player
UK only
9 countries
Global player
Planned
geo-
expansion
US, Portugal, Pol,
Czech
Spain, probably
Germany
Eastern Europe
Spain,
Germany
Poland,
Czech
Global trends in pet population
There are currently billions of pets worldwide
Families in the U.S., Brazil, EU and China alone account
for nearly 1 billion pets.
Pet ownership is rising globally, particularly in
millennial households, which tend to be smaller families
and have children later in life.
Expanding middle class is driving pet population
growth in emerging markets.
Pet ownership leads to improved human health
outcomes for people including better heart health, lower
levels of depression and anxiety, etc.
Brands & blockbusters Increasing brand value
 Limited market visibility below 50m€
 High competition density in all classes, in categories where in the
past there were small products only :
 Swine Vaccines : 22 brands > 10 m€ and several brands > 100m€
 Avian Vaccines: 38 brands > 10 m€ and several brands > 50m€
Blockbusters > $100m:
Zoetis, Elanco (and BI indirectly through their sales reporting)
qualify blocbkusters as products > $100m – 25 brands
 Zoetis : 8 (Apoquel, Simparica, Cytopoint, Draxxin, Revolution, Convenia,
Cerenia, Proheart)
 Merck : 2 (Bravecto, Porcilis PCV)
 Boehringer : 6 (Nexgard, Heartgard, Circoflex, Frontline, Ingelvac
PRRS, Vetmedin)
 Elanco : 8 (Seresto, Rumensin, Trifexis, Maxiban, Interceptor, Advantix,
Advantage, Galliprant)
700
170
20 6 2
1350
400
50 24 12
2+ m€ 10+ m€ 50+ m€ 100+ m€ 200+ m€
2008
2021
Number of brands
by category of revenue (Ceesa 2021)
Big trends in Animal Health
One Heath Concept
RUMA
Zoonozis
Feed the globe
Animal welfare
Compliance
Pet-humanization
Sustainability
Green Initiatives
Green sourcing
Cattle CO2 emission
Excrement environment
impact NL, DK, D
Technology innovation
Increased use of
telemedicine
Diagnostics
Tech. Devices
OnLine shops / e-commerc
PIMS
Inventory Management
Veterinary/Nurse
shortage
Automatized solutions
Retain employees
Increased cost
It is not the strongest of the
species that survives, nor
the most intelligent that
survives. It is the one that is
most adaptable to change.
Charles Darwin
Questions
Comments
Feedback

More Related Content

Similar to mHealth Israel- Animal Health Landscape

Dendreon Presentation
Dendreon PresentationDendreon Presentation
Dendreon Presentation
afa4
 
MaRS Best practices: Valuations in the biotech industry - Wayne Schnarr
MaRS Best practices: Valuations in the biotech industry - Wayne SchnarrMaRS Best practices: Valuations in the biotech industry - Wayne Schnarr
MaRS Best practices: Valuations in the biotech industry - Wayne Schnarr
MaRS Discovery District
 
MaRS Best practices: Valuations in the biotech industry - wayne schnarr
MaRS Best practices: Valuations in the biotech industry - wayne schnarrMaRS Best practices: Valuations in the biotech industry - wayne schnarr
MaRS Best practices: Valuations in the biotech industry - wayne schnarr
MaRS Discovery District
 
Warren Granger
Warren GrangerWarren Granger
Warren Grangerichil
 
Unilever.pptx
Unilever.pptxUnilever.pptx
Unilever.pptx
EmranHossen14
 
External Factor Evaluation
External Factor EvaluationExternal Factor Evaluation
External Factor Evaluation
prof.edbasa
 
Sm Case Jisha & Remya(2)
Sm Case Jisha & Remya(2)Sm Case Jisha & Remya(2)
Sm Case Jisha & Remya(2)guest78d8ca
 
CompareEuropeGroup - NOAH16 Berlin
CompareEuropeGroup - NOAH16 BerlinCompareEuropeGroup - NOAH16 Berlin
CompareEuropeGroup - NOAH16 Berlin
NOAH Advisors
 
Hyphens Pharma (SGX: 1J5)
Hyphens Pharma (SGX: 1J5)Hyphens Pharma (SGX: 1J5)
Hyphens Pharma (SGX: 1J5)
Kenny Chia Wei Hao
 
ALXN Buy Recommendation
ALXN Buy RecommendationALXN Buy Recommendation
ALXN Buy RecommendationEric Ebersole
 
Mera medicare
Mera medicareMera medicare
Mera medicare
RAHUL2014-2016
 
environmental models
  environmental models  environmental models
environmental modelsErslan Ashraf
 
Philips Business Presentation 2011
Philips Business Presentation 2011Philips Business Presentation 2011
Philips Business Presentation 2011stefanie_ronde
 
Philips Business Presentation 2011
Philips Business Presentation 2011Philips Business Presentation 2011
Philips Business Presentation 2011stefanie_ronde
 
Philips Business Presentation 2011
Philips Business Presentation 2011Philips Business Presentation 2011
Philips Business Presentation 2011stefanie_ronde
 
Final johnson and johnson revised 1
Final johnson and johnson revised 1Final johnson and johnson revised 1
Final johnson and johnson revised 1Shekhar Gurnani
 
GNC Presentation on Growth from 2011
GNC Presentation on Growth from 2011GNC Presentation on Growth from 2011
GNC Presentation on Growth from 2011
Neil Kimberley
 

Similar to mHealth Israel- Animal Health Landscape (20)

Dendreon Presentation
Dendreon PresentationDendreon Presentation
Dendreon Presentation
 
MaRS Best practices: Valuations in the biotech industry - Wayne Schnarr
MaRS Best practices: Valuations in the biotech industry - Wayne SchnarrMaRS Best practices: Valuations in the biotech industry - Wayne Schnarr
MaRS Best practices: Valuations in the biotech industry - Wayne Schnarr
 
MaRS Best practices: Valuations in the biotech industry - wayne schnarr
MaRS Best practices: Valuations in the biotech industry - wayne schnarrMaRS Best practices: Valuations in the biotech industry - wayne schnarr
MaRS Best practices: Valuations in the biotech industry - wayne schnarr
 
Warren Granger
Warren GrangerWarren Granger
Warren Granger
 
Unilever.pptx
Unilever.pptxUnilever.pptx
Unilever.pptx
 
External Factor Evaluation
External Factor EvaluationExternal Factor Evaluation
External Factor Evaluation
 
Ateneo efe
Ateneo efeAteneo efe
Ateneo efe
 
Ateneo efe
Ateneo efeAteneo efe
Ateneo efe
 
Sm Case Jisha & Remya(2)
Sm Case Jisha & Remya(2)Sm Case Jisha & Remya(2)
Sm Case Jisha & Remya(2)
 
CompareEuropeGroup - NOAH16 Berlin
CompareEuropeGroup - NOAH16 BerlinCompareEuropeGroup - NOAH16 Berlin
CompareEuropeGroup - NOAH16 Berlin
 
Growth
GrowthGrowth
Growth
 
Hyphens Pharma (SGX: 1J5)
Hyphens Pharma (SGX: 1J5)Hyphens Pharma (SGX: 1J5)
Hyphens Pharma (SGX: 1J5)
 
ALXN Buy Recommendation
ALXN Buy RecommendationALXN Buy Recommendation
ALXN Buy Recommendation
 
Mera medicare
Mera medicareMera medicare
Mera medicare
 
environmental models
  environmental models  environmental models
environmental models
 
Philips Business Presentation 2011
Philips Business Presentation 2011Philips Business Presentation 2011
Philips Business Presentation 2011
 
Philips Business Presentation 2011
Philips Business Presentation 2011Philips Business Presentation 2011
Philips Business Presentation 2011
 
Philips Business Presentation 2011
Philips Business Presentation 2011Philips Business Presentation 2011
Philips Business Presentation 2011
 
Final johnson and johnson revised 1
Final johnson and johnson revised 1Final johnson and johnson revised 1
Final johnson and johnson revised 1
 
GNC Presentation on Growth from 2011
GNC Presentation on Growth from 2011GNC Presentation on Growth from 2011
GNC Presentation on Growth from 2011
 

More from Levi Shapiro

Michigan HealthTech Market Map 2024 with Policy Makers, Academic Innovation C...
Michigan HealthTech Market Map 2024 with Policy Makers, Academic Innovation C...Michigan HealthTech Market Map 2024 with Policy Makers, Academic Innovation C...
Michigan HealthTech Market Map 2024 with Policy Makers, Academic Innovation C...
Levi Shapiro
 
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
Levi Shapiro
 
Prix Galien International 2024 Forum Program
Prix Galien International 2024 Forum ProgramPrix Galien International 2024 Forum Program
Prix Galien International 2024 Forum Program
Levi Shapiro
 
mHealth Israel_Healthcare Finance and M&A- What Comes Next
mHealth Israel_Healthcare Finance and M&A- What Comes NextmHealth Israel_Healthcare Finance and M&A- What Comes Next
mHealth Israel_Healthcare Finance and M&A- What Comes Next
Levi Shapiro
 
Healthcare Market Overview, May 2024: Funding, Financing and M&A, from Oppenh...
Healthcare Market Overview, May 2024: Funding, Financing and M&A, from Oppenh...Healthcare Market Overview, May 2024: Funding, Financing and M&A, from Oppenh...
Healthcare Market Overview, May 2024: Funding, Financing and M&A, from Oppenh...
Levi Shapiro
 
Version Bravo- The Springboard for Navy SEAL entrepreneurship, cohort 003
Version Bravo- The Springboard for Navy SEAL entrepreneurship, cohort 003Version Bravo- The Springboard for Navy SEAL entrepreneurship, cohort 003
Version Bravo- The Springboard for Navy SEAL entrepreneurship, cohort 003
Levi Shapiro
 
Radical Life Extension_Dr. Leon Peshkin_Dec 2023
Radical Life Extension_Dr. Leon Peshkin_Dec 2023Radical Life Extension_Dr. Leon Peshkin_Dec 2023
Radical Life Extension_Dr. Leon Peshkin_Dec 2023
Levi Shapiro
 
Israel’s Life Science Hub 2023 English Abstract.pdf
Israel’s Life Science Hub 2023 English Abstract.pdfIsrael’s Life Science Hub 2023 English Abstract.pdf
Israel’s Life Science Hub 2023 English Abstract.pdf
Levi Shapiro
 
Gil Bashe FINN Partners: The Future of Digital Health – Nose Dive or Transfor...
Gil Bashe FINN Partners: The Future of Digital Health – Nose Dive or Transfor...Gil Bashe FINN Partners: The Future of Digital Health – Nose Dive or Transfor...
Gil Bashe FINN Partners: The Future of Digital Health – Nose Dive or Transfor...
Levi Shapiro
 
Urgent Request and Call for Action for Ensuring Safety and Inclusivity at MIT
Urgent Request and Call for Action for Ensuring Safety and Inclusivity at MITUrgent Request and Call for Action for Ensuring Safety and Inclusivity at MIT
Urgent Request and Call for Action for Ensuring Safety and Inclusivity at MIT
Levi Shapiro
 
HLTH-2023-Digital-Catalouge.pdf
HLTH-2023-Digital-Catalouge.pdfHLTH-2023-Digital-Catalouge.pdf
HLTH-2023-Digital-Catalouge.pdf
Levi Shapiro
 
Baptist Health- Engineering the Future of Healthcare
Baptist Health- Engineering the Future of HealthcareBaptist Health- Engineering the Future of Healthcare
Baptist Health- Engineering the Future of Healthcare
Levi Shapiro
 
YEDA Techn Transfer at Weizmann Institute- Discord and Challenges in Academic...
YEDA Techn Transfer at Weizmann Institute- Discord and Challenges in Academic...YEDA Techn Transfer at Weizmann Institute- Discord and Challenges in Academic...
YEDA Techn Transfer at Weizmann Institute- Discord and Challenges in Academic...
Levi Shapiro
 
HADASIT: Tech Transfer and More in Life Science
HADASIT: Tech Transfer and More in Life ScienceHADASIT: Tech Transfer and More in Life Science
HADASIT: Tech Transfer and More in Life Science
Levi Shapiro
 
Presenting to Investors & the Media.pdf
Presenting to Investors & the Media.pdfPresenting to Investors & the Media.pdf
Presenting to Investors & the Media.pdf
Levi Shapiro
 
Nissan Elimelech, Founder, Augmedics: How I Built the World's First XR Surgic...
Nissan Elimelech, Founder, Augmedics: How I Built the World's First XR Surgic...Nissan Elimelech, Founder, Augmedics: How I Built the World's First XR Surgic...
Nissan Elimelech, Founder, Augmedics: How I Built the World's First XR Surgic...
Levi Shapiro
 
Beyeonics CEO, Ron Schneider, Advances in Medical XR
Beyeonics CEO, Ron Schneider, Advances in Medical XRBeyeonics CEO, Ron Schneider, Advances in Medical XR
Beyeonics CEO, Ron Schneider, Advances in Medical XR
Levi Shapiro
 
XRHealth Founder, Miki Levy
XRHealth Founder, Miki LevyXRHealth Founder, Miki Levy
XRHealth Founder, Miki Levy
Levi Shapiro
 
Digital Health in US Health Systems.pptx
Digital Health in US Health Systems.pptxDigital Health in US Health Systems.pptx
Digital Health in US Health Systems.pptx
Levi Shapiro
 
Course Syllabus (Digital Rosh): The Future of Digital Medicine- Biology, Gene...
Course Syllabus (Digital Rosh): The Future of Digital Medicine- Biology, Gene...Course Syllabus (Digital Rosh): The Future of Digital Medicine- Biology, Gene...
Course Syllabus (Digital Rosh): The Future of Digital Medicine- Biology, Gene...
Levi Shapiro
 

More from Levi Shapiro (20)

Michigan HealthTech Market Map 2024 with Policy Makers, Academic Innovation C...
Michigan HealthTech Market Map 2024 with Policy Makers, Academic Innovation C...Michigan HealthTech Market Map 2024 with Policy Makers, Academic Innovation C...
Michigan HealthTech Market Map 2024 with Policy Makers, Academic Innovation C...
 
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
 
Prix Galien International 2024 Forum Program
Prix Galien International 2024 Forum ProgramPrix Galien International 2024 Forum Program
Prix Galien International 2024 Forum Program
 
mHealth Israel_Healthcare Finance and M&A- What Comes Next
mHealth Israel_Healthcare Finance and M&A- What Comes NextmHealth Israel_Healthcare Finance and M&A- What Comes Next
mHealth Israel_Healthcare Finance and M&A- What Comes Next
 
Healthcare Market Overview, May 2024: Funding, Financing and M&A, from Oppenh...
Healthcare Market Overview, May 2024: Funding, Financing and M&A, from Oppenh...Healthcare Market Overview, May 2024: Funding, Financing and M&A, from Oppenh...
Healthcare Market Overview, May 2024: Funding, Financing and M&A, from Oppenh...
 
Version Bravo- The Springboard for Navy SEAL entrepreneurship, cohort 003
Version Bravo- The Springboard for Navy SEAL entrepreneurship, cohort 003Version Bravo- The Springboard for Navy SEAL entrepreneurship, cohort 003
Version Bravo- The Springboard for Navy SEAL entrepreneurship, cohort 003
 
Radical Life Extension_Dr. Leon Peshkin_Dec 2023
Radical Life Extension_Dr. Leon Peshkin_Dec 2023Radical Life Extension_Dr. Leon Peshkin_Dec 2023
Radical Life Extension_Dr. Leon Peshkin_Dec 2023
 
Israel’s Life Science Hub 2023 English Abstract.pdf
Israel’s Life Science Hub 2023 English Abstract.pdfIsrael’s Life Science Hub 2023 English Abstract.pdf
Israel’s Life Science Hub 2023 English Abstract.pdf
 
Gil Bashe FINN Partners: The Future of Digital Health – Nose Dive or Transfor...
Gil Bashe FINN Partners: The Future of Digital Health – Nose Dive or Transfor...Gil Bashe FINN Partners: The Future of Digital Health – Nose Dive or Transfor...
Gil Bashe FINN Partners: The Future of Digital Health – Nose Dive or Transfor...
 
Urgent Request and Call for Action for Ensuring Safety and Inclusivity at MIT
Urgent Request and Call for Action for Ensuring Safety and Inclusivity at MITUrgent Request and Call for Action for Ensuring Safety and Inclusivity at MIT
Urgent Request and Call for Action for Ensuring Safety and Inclusivity at MIT
 
HLTH-2023-Digital-Catalouge.pdf
HLTH-2023-Digital-Catalouge.pdfHLTH-2023-Digital-Catalouge.pdf
HLTH-2023-Digital-Catalouge.pdf
 
Baptist Health- Engineering the Future of Healthcare
Baptist Health- Engineering the Future of HealthcareBaptist Health- Engineering the Future of Healthcare
Baptist Health- Engineering the Future of Healthcare
 
YEDA Techn Transfer at Weizmann Institute- Discord and Challenges in Academic...
YEDA Techn Transfer at Weizmann Institute- Discord and Challenges in Academic...YEDA Techn Transfer at Weizmann Institute- Discord and Challenges in Academic...
YEDA Techn Transfer at Weizmann Institute- Discord and Challenges in Academic...
 
HADASIT: Tech Transfer and More in Life Science
HADASIT: Tech Transfer and More in Life ScienceHADASIT: Tech Transfer and More in Life Science
HADASIT: Tech Transfer and More in Life Science
 
Presenting to Investors & the Media.pdf
Presenting to Investors & the Media.pdfPresenting to Investors & the Media.pdf
Presenting to Investors & the Media.pdf
 
Nissan Elimelech, Founder, Augmedics: How I Built the World's First XR Surgic...
Nissan Elimelech, Founder, Augmedics: How I Built the World's First XR Surgic...Nissan Elimelech, Founder, Augmedics: How I Built the World's First XR Surgic...
Nissan Elimelech, Founder, Augmedics: How I Built the World's First XR Surgic...
 
Beyeonics CEO, Ron Schneider, Advances in Medical XR
Beyeonics CEO, Ron Schneider, Advances in Medical XRBeyeonics CEO, Ron Schneider, Advances in Medical XR
Beyeonics CEO, Ron Schneider, Advances in Medical XR
 
XRHealth Founder, Miki Levy
XRHealth Founder, Miki LevyXRHealth Founder, Miki Levy
XRHealth Founder, Miki Levy
 
Digital Health in US Health Systems.pptx
Digital Health in US Health Systems.pptxDigital Health in US Health Systems.pptx
Digital Health in US Health Systems.pptx
 
Course Syllabus (Digital Rosh): The Future of Digital Medicine- Biology, Gene...
Course Syllabus (Digital Rosh): The Future of Digital Medicine- Biology, Gene...Course Syllabus (Digital Rosh): The Future of Digital Medicine- Biology, Gene...
Course Syllabus (Digital Rosh): The Future of Digital Medicine- Biology, Gene...
 

Recently uploaded

Netter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdfNetter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdf
BrissaOrtiz3
 
Knee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdfKnee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdf
vimalpl1234
 
Ophthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE examOphthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE exam
KafrELShiekh University
 
Temporomandibular Joint By RABIA INAM GANDAPORE.pptx
Temporomandibular Joint By RABIA INAM GANDAPORE.pptxTemporomandibular Joint By RABIA INAM GANDAPORE.pptx
Temporomandibular Joint By RABIA INAM GANDAPORE.pptx
Dr. Rabia Inam Gandapore
 
263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,
sisternakatoto
 
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptxMaxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
Journal Article Review on Rasamanikya
Journal Article Review on RasamanikyaJournal Article Review on Rasamanikya
Journal Article Review on Rasamanikya
Dr. Jyothirmai Paindla
 
NVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control programNVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control program
Sapna Thakur
 
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.GawadHemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
NephroTube - Dr.Gawad
 
SURGICAL ANATOMY OF THE RETROPERITONEUM, ADRENALS, KIDNEYS AND URETERS.pptx
SURGICAL ANATOMY OF THE RETROPERITONEUM, ADRENALS, KIDNEYS AND URETERS.pptxSURGICAL ANATOMY OF THE RETROPERITONEUM, ADRENALS, KIDNEYS AND URETERS.pptx
SURGICAL ANATOMY OF THE RETROPERITONEUM, ADRENALS, KIDNEYS AND URETERS.pptx
Bright Chipili
 
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Oleg Kshivets
 
Cardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdfCardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdf
shivalingatalekar1
 
Role of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of HyperthyroidismRole of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of Hyperthyroidism
Dr. Jyothirmai Paindla
 
Top Effective Soaps for Fungal Skin Infections in India
Top Effective Soaps for Fungal Skin Infections in IndiaTop Effective Soaps for Fungal Skin Infections in India
Top Effective Soaps for Fungal Skin Infections in India
SwisschemDerma
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
د.محمود نجيب
 
Top 10 Best Ayurvedic Kidney Stone Syrups in India
Top 10 Best Ayurvedic Kidney Stone Syrups in IndiaTop 10 Best Ayurvedic Kidney Stone Syrups in India
Top 10 Best Ayurvedic Kidney Stone Syrups in India
Swastik Ayurveda
 
Non-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdfNon-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdf
MedicoseAcademics
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Saeid Safari
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
Dr. Vinay Pareek
 
Integrating Ayurveda into Parkinson’s Management: A Holistic Approach
Integrating Ayurveda into Parkinson’s Management: A Holistic ApproachIntegrating Ayurveda into Parkinson’s Management: A Holistic Approach
Integrating Ayurveda into Parkinson’s Management: A Holistic Approach
Ayurveda ForAll
 

Recently uploaded (20)

Netter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdfNetter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdf
 
Knee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdfKnee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdf
 
Ophthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE examOphthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE exam
 
Temporomandibular Joint By RABIA INAM GANDAPORE.pptx
Temporomandibular Joint By RABIA INAM GANDAPORE.pptxTemporomandibular Joint By RABIA INAM GANDAPORE.pptx
Temporomandibular Joint By RABIA INAM GANDAPORE.pptx
 
263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,
 
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptxMaxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
 
Journal Article Review on Rasamanikya
Journal Article Review on RasamanikyaJournal Article Review on Rasamanikya
Journal Article Review on Rasamanikya
 
NVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control programNVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control program
 
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.GawadHemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
 
SURGICAL ANATOMY OF THE RETROPERITONEUM, ADRENALS, KIDNEYS AND URETERS.pptx
SURGICAL ANATOMY OF THE RETROPERITONEUM, ADRENALS, KIDNEYS AND URETERS.pptxSURGICAL ANATOMY OF THE RETROPERITONEUM, ADRENALS, KIDNEYS AND URETERS.pptx
SURGICAL ANATOMY OF THE RETROPERITONEUM, ADRENALS, KIDNEYS AND URETERS.pptx
 
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
 
Cardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdfCardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdf
 
Role of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of HyperthyroidismRole of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of Hyperthyroidism
 
Top Effective Soaps for Fungal Skin Infections in India
Top Effective Soaps for Fungal Skin Infections in IndiaTop Effective Soaps for Fungal Skin Infections in India
Top Effective Soaps for Fungal Skin Infections in India
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
 
Top 10 Best Ayurvedic Kidney Stone Syrups in India
Top 10 Best Ayurvedic Kidney Stone Syrups in IndiaTop 10 Best Ayurvedic Kidney Stone Syrups in India
Top 10 Best Ayurvedic Kidney Stone Syrups in India
 
Non-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdfNon-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdf
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
 
Integrating Ayurveda into Parkinson’s Management: A Holistic Approach
Integrating Ayurveda into Parkinson’s Management: A Holistic ApproachIntegrating Ayurveda into Parkinson’s Management: A Holistic Approach
Integrating Ayurveda into Parkinson’s Management: A Holistic Approach
 

mHealth Israel- Animal Health Landscape

  • 2. Global macroeconomical outlook AH industry trends Implication on AH industry AGENDA 1 2 3
  • 4. Impacts on Animal Health Industry Currency & energy prices War in Ukraine weakens € Europe’s gas and oil = risk of recession Outlook Dip briefly below parity and to rally in the next 18 month at 1,02 to 1,08 Consensus Lower oil price strating from autumn-end 22 and for the Brent price to decline $90-95 in 23 and lower $85-90 in 24 The US dollar is greatly exagerated Interest rates are rising faster in the US = More appealing Stronger US growth -> increased invest in the US  increased demand for dollars The mid term PUSH FOR GREENIFICATION AND RENEWABLES
  • 5. Impacts on Animal Health Industry Inflation Growth Unemployment Costs Recessionary figures Lower growth (ELAN-) High demand labour =War fot Talent One-off bonuses Rising Inflation Producers/Inputs costs is rising Growth margins squeezed Costumers overall want value for money High single digit price increase in 2023
  • 7. Impacts on Animal Health Industry Implications CORPORATIZATION PET PARENT AND CONSUMER POWER ATTRACTIVITY CASH Cost and availability of cash is changing which means that there is again a cost associated to taking risk = investors start being more selective In this context, attractivity of the AH sector is increased, especially in Pets, given the track record of resilience of the sector vs. other investment opportunities. We will continue to see M&A activity and R&D investment in the sector. It will continue to increase in the AH, with megatrends like online 24/7 availability omnichannel, pet as family member, steady increase of pet plans / pet insurance / data driven personalization. This creates value in the market for agile companies. Despite the increased cost of money, the predictability and history of AH and veterinary business in the last financial crises and the early stage of vet clinics consolidations in many markets are strong drivers for continued, fast-paced corporatization to continue.
  • 9. Consultative Customers Transactional Customers Know what they want Treat you as commodity Digital interaction Cost focus Buy on price Short term Farms, trades, on-line shop, independent, etc. Share problems Value your value add Digital & analogue interaction Advice focus Buy on expertise and trust Long term IL / CA Corporates & GPOs DECADE AGO 10% of customers were one or the other, with the vast majority somewhere in the middle, willing to pay a little extra for some advice more want deeper consultative relationships more buy transactionally TODAY The middle is going away as more customers are moving to the extremes Customers’ mindset change
  • 10. Vet Landscape Evolution 2022-2025 Independent Vet clinics GPO’s Corporates  Companion Animals +++  Equine consolidating ++ Market consolidation UK >65% Netherlands >50% Germany; Belgium; France >25% Spain - Poland - Czech Success factor aggregating demand for smaller individual clinics to stay competitive
  • 11. Corporate landscape in Europe (data Q2 2022) A number of large, well capitalized veterinary strategic accounts are expanding Founded 2011 1999 2001 2015 2011 1987 2000 Ownership EQT (Silverlake and Nestlé) Public Pets At Home BC Partners Mars Banfield/VCA CVC Capital Partners Vimian Surgeries >2.200 (>900 UK) >500 >440 >260 in UK & 250 outside UK 450 (+100 in UK) 374 4500 incl 1100 USA Direct to Pet owner PDOL and MyFamilyVet Developing online shop Yes VetUK eshop, hired Amazon managers Pilot eshop in Sweden Highland GER Geographi Presence 19 countries Global player UK, Netherlands, Republic of Ireland UK only UK, Australia, New Zealand, Italy, France 14 countries Global player UK only 9 countries Global player Planned geo- expansion US, Portugal, Pol, Czech Spain, probably Germany Eastern Europe Spain, Germany Poland, Czech
  • 12. Global trends in pet population There are currently billions of pets worldwide Families in the U.S., Brazil, EU and China alone account for nearly 1 billion pets. Pet ownership is rising globally, particularly in millennial households, which tend to be smaller families and have children later in life. Expanding middle class is driving pet population growth in emerging markets. Pet ownership leads to improved human health outcomes for people including better heart health, lower levels of depression and anxiety, etc.
  • 13. Brands & blockbusters Increasing brand value  Limited market visibility below 50m€  High competition density in all classes, in categories where in the past there were small products only :  Swine Vaccines : 22 brands > 10 m€ and several brands > 100m€  Avian Vaccines: 38 brands > 10 m€ and several brands > 50m€ Blockbusters > $100m: Zoetis, Elanco (and BI indirectly through their sales reporting) qualify blocbkusters as products > $100m – 25 brands  Zoetis : 8 (Apoquel, Simparica, Cytopoint, Draxxin, Revolution, Convenia, Cerenia, Proheart)  Merck : 2 (Bravecto, Porcilis PCV)  Boehringer : 6 (Nexgard, Heartgard, Circoflex, Frontline, Ingelvac PRRS, Vetmedin)  Elanco : 8 (Seresto, Rumensin, Trifexis, Maxiban, Interceptor, Advantix, Advantage, Galliprant) 700 170 20 6 2 1350 400 50 24 12 2+ m€ 10+ m€ 50+ m€ 100+ m€ 200+ m€ 2008 2021 Number of brands by category of revenue (Ceesa 2021)
  • 14. Big trends in Animal Health One Heath Concept RUMA Zoonozis Feed the globe Animal welfare Compliance Pet-humanization Sustainability Green Initiatives Green sourcing Cattle CO2 emission Excrement environment impact NL, DK, D Technology innovation Increased use of telemedicine Diagnostics Tech. Devices OnLine shops / e-commerc PIMS Inventory Management Veterinary/Nurse shortage Automatized solutions Retain employees Increased cost
  • 15. It is not the strongest of the species that survives, nor the most intelligent that survives. It is the one that is most adaptable to change. Charles Darwin

Editor's Notes

  1. Consolidation: increasing presence and role of corporates and buying groups, meanwhile number of independent vet clinics is decreasing. Only the bigger and more sophisticated independent clinics will remain and our focus should be there (on top of corporates and buying groups).